Reviews Supplements Retinal Disease Guide November 2015 : Page 1

SUPPLEMENT TO NOVEMBER 2015 Anti-VEGF Agents in Practice What have we learned from a decade of study and clinical use? Our experts review. Neovascularization: What is it and What Does it Mean? By Mariem Abdou, OD, and Joseph W. Sowka, OD Clinical Manifestations of VEGF-Mediated Retinal Disease By Julie Rodman, OD, MS, and Sherrol A. Reynolds, OD Stemming the Tide: How Anti-VEGF Therapies Confront Neovascularization By Christopher L. Suhr, OD The Optometrist’s Role in Anti-VEGF Therapy By Julie Torbit, OD and Brad Sutton, OD NOVEMBER NOV EMB ER 2015 EM 20 15 REV REVIEW IEW OF OP OPTOMETRY TOMETR TRY 1

Next Page

Publication List
Using a screen reader? Click Here